Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Dylan Hampton"'
Autor:
Hector Bonilla, Dylan Hampton, Erika G. Marques de Menezes, Xutao Deng, José G. Montoya, Jill Anderson, Philip J. Norris
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Myalgic encephalomyelitis, or chronic fatigue syndrome (ME/CFS) is a serious disease whose cause has yet to be identified. Objective markers of the disease are also not well understood and would serve as important tools in diagnosis and management. O
Externí odkaz:
https://doaj.org/article/dc675e6ad5854658ba3af48fd542e9cd
Autor:
Sheila M Keating, Wes Rountree, Eduard Grebe, Andrea L Pappas, Mars Stone, Dylan Hampton, Christopher A Todd, Marek S Poniewierski, Ana Sanchez, Cassandra G Porth, Thomas N Denny, Michael P Busch, EQAPOL Limiting Antigen (LAg) Incidence Assay External Quality Assurance (EQA) Program
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222290 (2019)
Laboratory assays for identifying recent HIV-1 infections are widely used for estimating incidence in cross-sectional population-level surveys in global HIV-1surveillance. Adequate assay and laboratory performance are required to ensure accurate inci
Externí odkaz:
https://doaj.org/article/d55a41e9565d4576b93b4d0c95f00e09
Autor:
Joseph B Sempa, Alex Welte, Michael P Busch, Jake Hall, Dylan Hampton, Shelley N Facente, Sheila M Keating, Kara Marson, Neil Parkin, Christopher D Pilcher, Gary Murphy, Eduard Grebe, Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA)
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0220345 (2019)
BackgroundTwo manufacturers, Maxim Biomedical and Sedia Biosciences Corporation, supply CDC-approved versions of the HIV-1 Limiting Antigen Avidity EIA (LAg) for detecting 'recent' HIV infection in cross-sectional incidence estimation. This study ass
Externí odkaz:
https://doaj.org/article/d84c3385c34e4c6ca1a449a372057bd7
Autor:
Nathan W Cummins, Stacey Rizza, Mark R Litzow, Stephane Hua, Guinevere Q Lee, Kevin Einkauf, Tae-Wook Chun, Frank Rhame, Jason V Baker, Michael P Busch, Nicolas Chomont, Patrick G Dean, Rémi Fromentin, Ashley T Haase, Dylan Hampton, Sheila M Keating, Steven M Lada, Tzong-Hae Lee, Sekar Natesampillai, Douglas D Richman, Timothy W Schacker, Stephen Wietgrefe, Xu G Yu, Joseph D Yao, John Zeuli, Mathias Lichterfeld, Andrew D Badley
Publikováno v:
PLoS Medicine, Vol 14, Iss 11, p e1002461 (2017)
BACKGROUND:Notwithstanding 1 documented case of HIV-1 cure following allogeneic stem cell transplantation (allo-SCT), several subsequent cases of allo-SCT in HIV-1 positive individuals have failed to cure HIV-1 infection. The aim of our study was to
Externí odkaz:
https://doaj.org/article/6cb0f7ce4309430794213dddfb5bf122
Autor:
Hector Bonilla, Dylan Hampton, Erika G. Marques de Menezes, Xutao Deng, José G. Montoya, Jill Anderson, Philip J. Norris
Publikováno v:
Frontiers in immunology. 13
Myalgic encephalomyelitis, or chronic fatigue syndrome (ME/CFS) is a serious disease whose cause has yet to be identified. Objective markers of the disease are also not well understood and would serve as important tools in diagnosis and management. O
Autor:
James C. Zimring, Walter Bialkowski, Nelly Gefter, Greg Brewer, Stacy M Endres-Dighe, Dylan Hampton, Mark T. Gladwin, Marion C. Lanteri, Thomas Raife, Sonia Bakkour, Karla Murcia, Grier P. Page, Mila Lebedeva, Val Rychka, Xiaoyun Fu, Tamir Kanias, Steve Kleinman, Michael P. Busch, Mars Stone, Derek Sinchar, Adam Jakub, Sheila M. Keating
Publikováno v:
Transfusion. 59:57-66
BACKGROUND The major aims of the RBC-Omics study were to evaluate the genomic and metabolomic determinants of spontaneous and stress-induced hemolysis during RBC storage. This study was unique in scale and design to allow evaluation of RBC donations
Autor:
Roberta Bruhn, Rahima Fayed, Eduard Grebe, Alan E. Williams, Brian Custer, Claire Quiner, Steve A. Anderson, Clara Di Germanio, Debra Kessler, Susan L. Stramer, Phillip C. Williamson, Michael P. Busch, Rita Reik, Simone A. Glynn, Dylan Hampton
Publikováno v:
TransfusionREFERENCES. 60(10)
BACKGROUND Monitoring of transfusion-transmissible infections in the blood supply is essential for blood safety, as the donor population is not static, and changes in policy, donor behavior, or other factors could increase the risk of recipient infec
Autor:
Michael P. Busch, Joshua C. Cyktor, Deborah McMahon, Sheila M. Keating, Ronald J. Bosch, Dylan Hampton, Rajesh T. Gandhi, John W. Mellors, Christina M. Lalama, Actg A Study Team, R.B. Jones, Joseph J. Eron
Publikováno v:
J Acquir Immune Defic Syndr
BACKGROUND: In people with HIV on antiretroviral therapy (ART), the relationship between HIV-specific immune responses and measures of HIV persistence is uncertain. METHODS: We evaluated 101 individuals on suppressive ART in the AIDS Clinical Trials
Autor:
Jake Hall, Joseph Sempa, Gary Murphy, Dylan Hampton, Shelley N. Facente, Alex Welte, Kara Marson, Eduard Grebe, Neil Parkin, Sheila M. Keating, CD Pilcher, Michael P. Busch
BackgroundTwo manufacturers, Maxim Biomedical and Sedia Biosciences Corporation, supply US CDC-approved versions of the HIV-1 Limiting Antigen Avidity EIA (LAg assay) for detecting ‘recent’ HIV infection in cross-sectional incidence estimation. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46070e61e0a21287e62c18fe2ba1c057
https://doi.org/10.1101/572677
https://doi.org/10.1101/572677
Autor:
Marek S. Poniewierski, Cassandra G Porth, Christopher A. Todd, Andrea L. Pappas, Eduard Grebe, Mars Stone, Ana M. Sanchez, Eqapol Limiting Antigen Program, Sheila M. Keating, Thomas N. Denny, Michael P. Busch, Wes Rountree, Dylan Hampton
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222290 (2019)
PLoS ONE
PLoS ONE
Laboratory assays for identifying recent HIV-1 infections are widely used for estimating incidence in cross-sectional population-level surveys in global HIV-1surveillance. Adequate assay and laboratory performance are required to ensure accurate inci